Literature DB >> 26245370

Corrigendum: Progesterone receptor modulates ERα action in breast cancer.

Hisham Mohammed, I Alasdair Russell, Rory Stark, Oscar M Rueda, Theresa E Hickey, Gerard A Tarulli, Aurelien A Serandour, Stephen N Birrell, Alejandra Bruna, Amel Saadi, Suraj Menon, James Hadfield, Michelle Pugh, Ganesh V Raj, Gordon D Brown, Clive D'Santos, Jessica L L Robinson, Grace Silva, Rosalind Launchbury, Charles M Perou, John Stingl, Carlos Caldas, Wayne D Tilley, Jason S Carroll.   

Abstract

Entities:  

Year:  2015        PMID： 26245370     DOI： 10.1038/nature14959

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Progesterone receptor modulates ERα action in breast cancer.

Authors:  Hisham Mohammed; I Alasdair Russell; Rory Stark; Oscar M Rueda; Theresa E Hickey; Gerard A Tarulli; Aurelien A Serandour; Aurelien A A Serandour; Stephen N Birrell; Alejandra Bruna; Amel Saadi; Suraj Menon; James Hadfield; Michelle Pugh; Ganesh V Raj; Gordon D Brown; Clive D'Santos; Jessica L L Robinson; Grace Silva; Rosalind Launchbury; Charles M Perou; John Stingl; Carlos Caldas; Wayne D Tilley; Jason S Carroll
Journal:  Nature       Date:  2015-07-08       Impact factor: 49.962
  1 in total
  7 in total

1.  Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery.

Authors:  Gianluca Vanni; Marco Materazzo; Marco Pellicciaro; Ljuba Morando; Ilaria Portarena; Lucia Anemona; Maria Rolando D'Angelillo; Rosaria Barbarino; Agostino Chiaravalloti; Rosaria Meucci; Tommaso Perretta; Camilla Deiana; Paolo Orsaria; Jonathan Caspi; Chiara Adriana Pistolese; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.

Authors:  Kelley Salem; Manoj Kumar; Ginny L Powers; Justin J Jeffery; Yongjun Yan; Aparna M Mahajan; Amy M Fowler
Journal:  Radiology       Date:  2017-09-25       Impact factor: 11.105

3.  GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network.

Authors:  Motoki Takaku; Sara A Grimm; John D Roberts; Kaliopi Chrysovergis; Brian D Bennett; Page Myers; Lalith Perera; Charles J Tucker; Charles M Perou; Paul A Wade
Journal:  Nat Commun       Date:  2018-03-13       Impact factor: 14.919

4.  The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability.

Authors:  Shinjini Ganguly; Divya Naik; Andrew Muskara; Omar Y Mian
Journal:  Endocrinology       Date:  2021-01-01       Impact factor: 4.736

5.  Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.

Authors:  Sasagu Kurozumi; Hiroshi Matsumoto; Kenichi Inoue; Katsunori Tozuka; Yuji Hayashi; Masafumi Kurosumi; Tetsunari Oyama; Takaaki Fujii; Jun Horiguchi; Hiroyuki Kuwano
Journal:  PLoS One       Date:  2018-08-06       Impact factor: 3.240

Review 6.  Estrogen Receptors and Ubiquitin Proteasome System: Mutual Regulation.

Authors:  Irina V Kondakova; Elena E Shashova; Evgenia A Sidenko; Tatiana M Astakhova; Liudmila A Zakharova; Natalia P Sharova
Journal:  Biomolecules       Date:  2020-03-26

Review 7.  Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer.

Authors:  Angeles C Tecalco-Cruz; Josué O Ramírez-Jarquín
Journal:  World J Clin Oncol       Date:  2018-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.